Repeated use of pre- and postcoital hormonal contraception for prevention of pregnancy

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 9, 2014, Pages

  Halpern, Vera ^a   Raymond, Elizabeth G ^b   Lopez, Laureen M ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b GYNUITY HEALTH PROJECTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; POSTCOITUS CONTRACEPTIVE AGENT;

ASIA; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CONTRACEPTION; EUROPE; HORMONAL CONTRACEPTION; HUMAN; MENSTRUAL IRREGULARITY; PREGNANCY; PREGNANCY RATE; PREVENTION; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; WESTERN HEMISPHERE; CHEMICALLY INDUCED; COITUS; FEMALE; MENSTRUATION DISORDER; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

COITUS; CONTRACEPTIVES, ORAL, HORMONAL; CONTRACEPTIVES, POSTCOITAL; FEMALE; HUMANS; LEVONORGESTREL; MENSTRUATION DISTURBANCES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84922043481     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007595.pub3     Document Type: Review

References (55)

1. Canzler VE, Ahrendt HJ, Ahrendt S. Experience with LNG for postcoital contraception. Zentralblatt für Gynäkologie 1984;106:1182-91.
2. Chernev T, Ivanov S, Dikov I, Stemenkova R. Prospective study of contraception with LNG. Planned Parenthood in Europe 1995;24(2):25.
3. Cox HJE. The pre-coital use of mini-dosage progestagens. Journal Reproduction and Fertility 1968;Suppl 5:167-72.
4. Echeverry G, Sarria C. High doses of d-norgestrel as a postcoital contraception. Report on file 1974.
5. He CH, Shi YE, Xu JQ, Van Look PFA. A multicenter clinical study on two types of LNG tablets administered for postcoital contraception. International Journal of Gynecology and Obstetrics 1991;36:43-8.
6. Kesseru E, Larranga A, Parada J. Postcoital contraception with d-Norgestrel. Contraception 1973;7:367-79.
7. Klawe H, Iwaszkiewicz J. Preliminary results of investigations of Postinor. Report on file 1984; Vol. 26:29.
8. Kliment V, Ziak F, Stanislav D, Hronec M. Postcoital contraception. Ceskoslovenska Gynekologie 1986;51:103-5.
9. Larranga A, Winterhaltel M, Sartoretto JN. Evaluation of d-Norgestrel 1.0 mg as a post-coital contraceptive. International Journal of Fertility 1975;20:156-60.
10. Mischler TW, Rubio B, Larranga A, Guiloff E, Moggia A. Further experience with quingestanol acetate as a postcoital oral contraceptive. Contraception 1974;9:221-5.
11. Moggia A, Beauquis A, Ferrari F, Torrado M, Alonso J, Koremblit E, et al. The use of progestogens as postcoital oral contraceptives. Journal of Reproductive Medicine 1974;13:58-61.
12. Nirapathpongporn A, Antarikanonda P. Postcoital contraception with 0.75 mg LNG (Postinor) in Thai women. Report on file (data collected 1984 to 1985).
13. Rubio B, Berman E, Larranga A, Guiloff E. A new postcoital oral contraceptive. Contraception 1970;1:303-13.
14. Sas M, Farkas M, Apro G. On the oral postcoital contraceptive Postinor containing 0.75mg of d-norgestrel per tablet. Report on file (undated).
15. Schering AG. Clinical results of SH 9.0999 P (post-coital pill containing 600 μg LNG) in semi-continuous use (as supplied 04 Nov 2008). Report on file 1978.
16. Seregely G. Results of a multicenter trial of Postinor. Therapia Hungarica 1982;30:72-8.
17. Szontagh FE, Kovacs L. Post-coital contraception with dienoestrol. Medical Gynaecology and Sociology 1969;4:36-7.
18. Halpern V. Pericoital oral contraception with levonorgestrel. http://clinicaltrials.gov/show/NCT00922233 (accessed 5 February 2014).
19. Taylor DJ, Lendvay A, Halpern V, Bahamondes LG, Fine PM, Ginde SY, et al. A single-arm study to evaluate the efficacy, safety and acceptability of pericoital oral contraception with levonorgestrel. Contraception 2014;89(3):215-21.
20. Bhattacharjee SK, Romeo J, Kononova ES, Pretnar-Darovec A, Saraya L, Shi YE, et al. Postcoital contraception with LNG during the peri-ovulatory phase of the menstrual cycle. Task Force on Post-ovulatory Methods for Fertility Regulation. Contraception 1987;36:275-86.
21. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Post-Ovulatory Methods of Fertility Regulation. Efficacy and side effects of immediate postcoital LNG used repeatedly for contraception. Contraception 2000;61:303-8.
22. Zanartu J, Dabancens A, Oberti C, Rodriquez-Bravo R, Garcia-Huidobro M. Low-dosage oral progestogens to control fertility. Obstetrics and Gynecology 1974;43:87-96.
23. Zanartu J, Oberti C. An oral progestogen as a coital contraceptive: experimental clinical study. In: Moghissi KS, Evans TN editor(s). Regulation of Human Fertility. Detroit (MI): Wayne State University Press, 1976:101-14.
24. Czekanowski R, Adamski M. Effectiveness of contraceptive Postinor. Report on file (undated).
25. Hetenyi G. Comparative study of anteovin, rigevidon and postinor in young people. Medicus Universalis Terapias Melleklet 1988;May:2-4.
26. Hurtado H, Kesseru E, Larranga A, Benavides G. Post-coital contraception with d-norgestrel: evaluation of nine doses. Reproduccion 1975;2:61.
27. Krymskaya ML, Khomasuridze AG. Clinical aspects of the use of current oral contraceptives. Akusherstvo Gynecologiya 1983;11:19-22.
28. Kulakov VI, Barinov AM, Prilepskaya VN. Contraceptive use of ovidon, rigevidon and postinor. Akusherstvo Gynecologiya 1983;11:22-4.
29. Orley J. Report on the clinical trial of Postinor. Report on file (undated).
30. Serov VN, Glebova VV, Shakhova AD. Clinical use of rigevidon, ovidon and postinor. Akusherstvo Gynecologiya 1983;11:17-9.
31. Szczurowicz A, Witczak A. Clinical evaluation of Postinor. Report on file undated.
32. Unzeitig V, Mullerova M, Buresova A, Soska J. Interception - three years of experience. Ceskoslovenska Gynekologie 1989;54:192-5.
33. Vasilev D, Katsarova M. Our experience with clinical testing of Postinor - a hormonal oral preparation for postcoital contraception [article in Bulgarian]. Akusherstvo i Ginekologiia 1983;22:239-42.
34. World Health Organization. Pericoital oral contraception with levonorgestrel among reproductive aged-women who have infrequent intercourse to investigate its safety and efficacy. https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=320673 (accessed 30 January 2014). [: ACTRN12611001037998]
35. American College of Obstetricians and Gynecologists. Emergency contraception. Practice Bulletin 2010; Vol. 112:1100-9.
36. Arowojolu AO, Adekunle AO. Perception and practice of emergency contraception by post-secondary school students in Southwest Nigeria. African Journal of Reproductive Health 2000;4:56-65.
37. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6.
38. Britwum PK. What one should know about the drug 'N' tablet. Ghana Pharmaceutical Journal 2006:67-8.
39. Croxatto HB, Ortiz ME, Muller AL. Mechanism of action of emergency contraception. Steroids 2003;68:1095-8.
40. Farkas M, Apro G, Sas M. Clinico-pharmacological examination of Postinor. Therapia Hungarica 1981;29:22-30.
41. Foster DG, Biggs MA, Grossman D, Schwarz EB. Interest in a pericoital pill among women in family planning and abortion clinics. Contraception 2013;88(1):141-6.
42. Frost J (Guttmacher Institute). Data on women who have infrequent sex. Email to: EG Raymond 6 July 2009.
43. He C, Shi Y, Liao D, Zhu Y, Xu J, Matlir SA, et al. Comparative cross-over pharmacokinetic study on two types of postcoital contraceptive tablets containing levonorgestrel. Contraception 1990;41:557-67.
44. Herbenick D, Reece M, Schick V, Sanders SA, Dodge B, Fortenberry JD. Sexual behaviors, relationships, and perceived health status among adult women in the United States: results from a national probability sample. Journal of Sexual Medicine 2010;7(Suppl 5):277-80.
45. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
46. Lerkiatbundit S, Reanmongkol W. Use of 0.75 mg levonorgestrel for postcoital contraception in Thailand. Journal of Clinical Pharmacy and Therapeutics 2000;25:185-90.
47. Lo SST, Ho P-C. Changes in contraceptive choice after emergency contraception. International Journal of Gynecology and Obstetrics 2012;118(3):223-6.
48. Morris JM, van Wagenen G. Interception: the use of postovulatory estrogens to prevent implantation. American Journal of Obstetrics and Gynecology 1973;115:101-6.
49. Novikova N, Weisberg E, Stanczyk FZ, Croxatto HB, Fraser IS. Effectiveness of LNG emergency contraception given before or after ovulation - a pilot study. Contraception 2007;75:112-8.
50. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
51. Seregely G, Vero T. Postcoital contraception with 0.75 mg d-Norgestrel (Postinor). Magyar Noorvosok Lapia 1977;40:31-4.
52. Taylor D (FHI 360). Interpretation of pooled pregnancy rate. Email to: EG Raymond 29 June 2009.
53. Trussell J. Methodological pitfalls in the analysis of contraceptive failure. Statistics in Medicine 1991;10:201-10.
54. Trussell J. Contraceptive failure in the United States. Contraception 2011;83:397-404.
55. Trussell J, Raymond EG, Cleland K. Emergency contraception: a last chance to prevent unintended pregnancy. http://ec.princeton.edu/questions/ec-review.pdf (accessed 4 February 2014).